VKH
PRPH

Virtu KCG Holdings’s ProPhase Labs PRPH Stock Holding History

Virtu KCG Holdings’s Portfolio PRPH Stock Details PRPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-1,578
Closed -$21K – 4133
2014
Q3 		$21K Buy
+1,578
New +$24.6K ﹤0.01% 3467

Other funds holding PRPH

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VIP
Vantage Investment Partners Kansas City, Missouri $1.45B AUM 18.96% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Virtu KCG Holdings's PRPH Position: Q4 2014 in Review

Virtu KCG Holdings sold out of ProPhase Labs (PRPH) in Q4 2014, closing a stake of 1,578 shares — an estimated $21K sold.

Virtu KCG Holdings first reported a position in PRPH in Q3 2014 and held it in 1 quarter. The position peaked at $21K in Q3 2014. 16 funds tracked by Wall St. Rank hold PRPH as of Q4 2014.

  • Virtu KCG Holdings reported no remaining ProPhase Labs position as of Q4 2014 after selling out during the quarter.
  • Virtu KCG Holdings sold 1,578 ProPhase Labs shares in Q4 2014, an estimated $21K.
  • Virtu KCG Holdings first reported a position in ProPhase Labs in Q3 2014 and held it in 1 quarter.
  • Virtu KCG Holdings's ProPhase Labs position peaked at $21K in Q3 2014.
  • 16 funds tracked by Wall St. Rank held ProPhase Labs as of Q4 2014.

Based on Virtu KCG Holdings's 13F filing for Q4 2014, filed 17 Feb 2015.